###
中国临床研究:2025,38(11):1660-1664
本文二维码信息
码上扫一扫!
血清软骨糖蛋白⁃39与线粒体解偶联蛋白2对耐药肺炎克雷伯菌脓毒症预后的预测价值
(安徽医科大学附属宿州医院 安徽省宿州市立医院检验科, 安徽 宿州 234000)
Predictive value of serum cartilage glycoprotein⁃39 and mitochondrial uncoupling protein 2 for prognosis of drug⁃resistant Klebsiella pneumoniae sepsis
(Department of Laboratory Medicine,Suzhou Municipal Hospital Affiliated to Anhui Medical University,Suzhou,Anhui 234000,China)
摘要
本文已被:浏览 225次   下载 103
投稿时间:2024-12-27   网络发布日期:2025-11-26
中文摘要: 目的 分析血清软骨糖蛋白-39(YKL-40)、线粒体解偶联蛋白(UCP)2与耐药肺炎克雷伯菌(KP)脓毒症的发生和预后的关系。方法 前瞻性选取安徽医科大学附属宿州医院2022年1月至2023年6月收治的100例耐药KP导致的脓毒症患者为研究组,另选取同期103例健康者为对照组。根据研究组患者28 d预后分为预后不良组(n=38)和预后良好组(n=62)。酶联免疫吸附试验(ELISA)检测血清 YKL-40、UCP2 水平。采用多因素logistic回归分析耐药KP脓毒症预后的影响因素;受试者工作特征(ROC)曲线分析血清YKL-40和UCP2对耐药KP脓毒症预后的预测价值。结果 研究组血清YKL-40、UCP2、降钙素原(PCT)水平和白细胞计数(WBC)均显著高于对照组(P<0.05)。预后不良组血清 YKL-40[(54.15±9.43)ng/mL vs(41.59±5.76)ng/mL,t=8.279,P<0.05]、UCP2[(175.42±26.81)ng/L vs(117.63±17.02)ng/L,t=13.198,P<0.05]水平均较预后良好组显著增加。预后不良组急性生理与慢性健康状况Ⅱ(APACHEⅡ)评分、序贯器官衰竭评估(SOFA)评分、PCT水平和WBC显著高于预后良好组(P<0.05)。Logistic回归结果显示,血清YKL-40(OR=1.522)、UCP2(OR=1.658)、APACHEⅡ评分(OR=1.885)、SOFA 评分(OR=1.973)和 PCT(OR=2.014)为耐药 KP 脓毒症预后的影响因素(P<0.05)。ROC 曲线分析显示,血清YKL-40预测耐药KP脓毒症预后的AUC为0.774(95%CI:0.680~0.852),敏感度为71.05%;血清UCP2预测的AUC为0.778(95%CI:0.683~0.855),敏感度为68.42%;血清YKL-40、UCP2联合预测的AUC为0.899(95%CI:0.822~0.950),敏感度为89.47%,联合预测的AUC显著高于血清YKL-40(Z=2.297,P=0.022)、UCP2(Z=2.152,P=0.031)单独预测的AUC。结论 血清YKL-40和UCP2在耐药KP脓毒症患者中水平较高,两者联合预测耐药KP脓毒症28 d预后的价值较高。
Abstract:Objective To analyze the association of serum levels of cartilage glycoprotein-39(YKL-40),and mitochondrial uncoupling protein 2(UCP2)with the occurrence and prognosis of drug-resistant Klebsiella pneumoniae(KP)sepsis. Methods Prospectively,100 patients with drug - resistant KP sepsis admitted to Suzhou Municipal Hospital Affiliated to Anhui Medical University from January 2022 to June 2023 were selected as the study group,and 103 healthy individuals during the same period were selected as the control group. The study group was further divided into a poor prognosis group(n=38)and a good prognosis group(n=62)based on the 28-day prognosis. Serum levels of YKL-40 and UCP2 were measured using enzyme-linked immunosorbent assay(ELISA). Multivariate logistic regression analysis was used to identify factors influencing the prognosis of drug - resistant KP sepsis. Receiver operating characteristic(ROC)curves were used to evaluate the predictive value of serum YKL-40 and UCP2 for the prognosis of drug-resistant KP sepsis. Results Serum levels of YKL-40,UCP2,procalcitonin(PCT),and white blood cell count(WBC)were significantly higher in the study group compared to those in the control group (P<0.05). The poor prognosis group had significantly higher serum levels of YKL-40[(54.15±9.43)ng/mL vs(41.59±5.76)ng/mL,t=8.279,P<0.05]and UCP2[(175.42 ± 26.81)ng/L vs(117.63 ± 17.02)ng/L,t=13.198,P<0.01]than those in the good prognosis group. Additionally,the Acute Physiology and Chronic Health Evaluation Ⅱ(APACHEⅡ)score,Sequential Organ Failure Assessment(SOFA)score,PCT,and WBC were significantly higher in the poor prognosis group than those in the good prognosis group(P<0.05). Logistic regression analysis identified serum YKL-40(OR=1.522),UCP2(OR=1.658),APACHEⅡscore(OR=1.885),SOFA score(OR=1.973),and PCT(OR=2.014)as factors influencing the prognosis of drug-resistant KP sepsis(P<0.05). ROC curve analysis showed that the area under the curve(AUC)for serum YKL-40 in predicting the prognosis of drug-resistant KP sepsis was 0.774(95%CI:0.680-0.852)with a sensitivity of 71.05%;for serum UCP2,the AUC was 0.778(95%CI:0.683-0.855)with a sensitivity of 68.42%. The combined prediction of serum YKL-40 and UCP2 had a sensitivity of 89.47% and an AUC of 0.899(95%CI:0.822-0.950),which was significantly higher than the AUC for serum YKL-40 alone(Z=2.297,P=0.022)or UCP2 alone(Z=2.152,P=0.031). Conclusion Serum levels of YKL- 40 and UCP2 are elevated in patients with drug-resistant KP sepsis,and their combined use has a high predictive value for 28-day prognosis of drug-resistant KP sepsis.
文章编号:     中图分类号:R631    文献标志码:A
基金项目:宿州市科技计划项目(SZSKJJZC031,SZZCZJ202229);安徽医科大学校科研基金项目(青年科学基金)(2021xkj081)
附件
引用文本:
周鹏鹏,夏宏林,刘玉岭,李梅,郝维敏.血清软骨糖蛋白⁃39与线粒体解偶联蛋白2对耐药肺炎克雷伯菌脓毒症预后的预测价值[J].中国临床研究,2025,38(11):1660-1664.

用微信扫一扫

用微信扫一扫